{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:09:43Z","timestamp":1780697383187,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ymgmr.2024.101060","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T13:06:56Z","timestamp":1706792816000},"page":"101060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and Genetic Aspects, and Treatment Outcome with Cerliponase Alfa"],"prefix":"10.1016","volume":"38","author":[{"given":"Norberto","family":"Guelbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar Mauricio","family":"Espitia Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Amoretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica","family":"Arteaga Arteaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora Graciela","family":"Atanacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Bazan Natacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellaine Doris Fernandes","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Denise Fernandes","family":"Carvalho de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s Mar\u00eda","family":"Denzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlane","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Giugni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Gonz\u00e1lez Moron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Guelbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulma Janneth","family":"Hern\u00e1ndez Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katiane","family":"Embiru\u00e7u Emilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Andr\u00e9s","family":"Kauffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nury Isabel","family":"Mancilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureano","family":"Marcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Marques Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Fischinger Moura de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Adri\u00e1n","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Andr\u00e9s","family":"Naranjo Fl\u00f3rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Luiz","family":"Pessoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Victoria","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Luz","family":"Solano Villareal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Sp\u00e9cola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina Marcela","family":"Tavera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javiera","family":"Tello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Troncoso Schifferli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Ugrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Magdalena","family":"Vaccarezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Mercedes","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March","key":"10.1016\/j.ymgmr.2024.101060_bb0005","first-page":"1","article-title":"Neuronal ceroid lipofuscinosis: the multifaceted approach to the clinical issues, an overview","volume":"13","author":"Simonati","year":"2022","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.ymgmr.2024.101060_bb0010","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","article-title":"Neuronal ceroid lipofuscinoses","volume":"1793","author":"Jalanko","year":"2009","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.ymgmr.2024.101060_bb0015","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3389\/fneur.2021.754045","article-title":"The genetic basis of phenotypic heterogeneity in the neuronal ceroid lipofuscinoses","volume":"12","author":"Gardner","year":"2021","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.ymgmr.2024.101060_bb0020","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/humu.23860","article-title":"Mutation update: review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease","volume":"40","author":"Gardner","year":"2019","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.ymgmr.2024.101060_bb0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1399-0004.2009.01214.x","article-title":"An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients","volume":"76","author":"Kohan","year":"2009","journal-title":"Clin. Genet."},{"issue":"4","key":"10.1016\/j.ymgmr.2024.101060_bb0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/jpc.15250","article-title":"Revealing the clinical phenotype of atypical neuronal ceroid lipofuscinosis type 2 disease: insights from the largest cohort in the world","volume":"57","author":"Louren\u00e7o","year":"2021","journal-title":"J. Paediatr. Child Health"},{"issue":"10","key":"10.1016\/j.ymgmr.2024.101060_bb0035","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.bbadis.2015.05.003","article-title":"The neuronal ceroid lipofuscinoses program: a translational research experience in Argentina","volume":"1852","author":"Kohan","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101060_bb0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.gene.2012.12.058","article-title":"Neuronal ceroid lipofuscinosis type CLN2: a new rationale for the construction of phenotypic subgroups based on a survey of 25 cases in South America","volume":"516","author":"Kohan","year":"2013","journal-title":"Gene."},{"key":"10.1016\/j.ymgmr.2024.101060_bb0045","article-title":"Real world effectiveness of cerliponase alfa in classical and atypical patients. A case series","volume":"27","author":"Espitia Segura","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101060_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-0004.2008.01054.x","article-title":"The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland","volume":"74","author":"Moore","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgmr.2024.101060_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pediatrneurol.2017.01.034","article-title":"Management strategies for CLN2 disease","volume":"69","author":"Williams","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgmr.2024.101060_bb0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00018-010-0468-6","article-title":"Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function","volume":"68","author":"Getty","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101060_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-021-01813-5","article-title":"Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients","volume":"16","author":"Mole","year":"2021","journal-title":"Orphanet. J. Rare Dis."},{"issue":"S01","key":"10.1016\/j.ymgmr.2024.101060_bb0070","article-title":"Natural history of CLN2 disease: quantitative assessment of disease characteristics and rate of progression","volume":"47","author":"Nickel","year":"2016","journal-title":"Neuropediatrics"},{"issue":"10","key":"10.1016\/j.ymgmr.2024.101060_bb0075","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bbadis.2006.07.001","article-title":"Diagnosis of the neuronal ceroid lipofuscinoses: an update","volume":"1762","author":"Williams","year":"2006","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"8","key":"10.1016\/j.ymgmr.2024.101060_bb0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S2352-4642(18)30179-2","article-title":"Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study","volume":"2","author":"Nickel","year":"2018","journal-title":"Lancet Child Adolesc. Heal."},{"issue":"5","key":"10.1016\/j.ymgmr.2024.101060_bb0085","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101060_bb0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00401-008-0349-3","article-title":"Atypical CLN2 with later onset and prolonged course: a neuropathologic study showing different sensitivity of neuronal subpopulations to TPP1 deficiency","volume":"116","author":"Elleder","year":"2008","journal-title":"Acta Neuropathol."},{"issue":"1\u20132","key":"10.1016\/j.ymgmr.2024.101060_bb0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2016.07.011","article-title":"Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): expert recommendations for early detection and laboratory diagnosis","volume":"119","author":"Fietz","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2024.101060_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/epi.17269","article-title":"Value of genetic testing for pediatric epilepsy: driving earlier diagnosis of ceroid lipofuscinosis type 2 batten disease","author":"Leal-Pardinas","year":"2022","journal-title":"Epilepsia."},{"key":"10.1016\/j.ymgmr.2024.101060_bb0105","year":"2019"},{"issue":"4","key":"10.1016\/j.ymgmr.2024.101060_bb0110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajmg.10660","article-title":"Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations","volume":"112","author":"Steinfeld","year":"2002","journal-title":"Am. J. Med. Genet. [Internet]"},{"key":"10.1016\/j.ymgmr.2024.101060_bb0115","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/01.wnl.0000267885.47092.40","article-title":"Neurological deterioration in late infantile neuronal ceroid lipofuscinosis","volume":"69","author":"Worgall","year":"2007","journal-title":"Neurology."},{"key":"10.1016\/j.ymgmr.2024.101060_bb0120","author":"Wyrwich"},{"key":"10.1016\/j.ymgmr.2024.101060_bb0125","doi-asserted-by":"crossref","DOI":"10.1007\/s12311-023-01543-3","article-title":"Scale for the assessment and rating of Ataxia (SARA): development of a training tool and certification program","author":"Grobe-Einsler","year":"2023","journal-title":"Cerebellum."},{"issue":"6","key":"10.1016\/j.ymgmr.2024.101060_bb0130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/0883073820977997","article-title":"Cerliponase alfa for the treatment of atypical phenotypes of CLN2 disease: a retrospective case series","volume":"36","author":"Wibbeler","year":"2021","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgmr.2024.101060_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejpn.2020.12.002","article-title":"Cerliponase alfa changes the natural history of children with neuronal ceroid lipofuscinosis type 2: the first French cohort","volume":"30","author":"Estublier","year":"2021","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"20","key":"10.1016\/j.ymgmr.2024.101060_bb0140","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2024.101060_bb0145","series-title":"International Encyclopedia of Ethics","article-title":"Declaration of Helsinki","author":"Holm","year":"2013"},{"issue":"8","key":"10.1016\/j.ymgmr.2024.101060_bb0150","first-page":"797","article-title":"Barriers and considerations for diagnosing rare diseases in indigenous populations","author":"D\u2019Angelo","year":"2020","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymgmr.2024.101060_bb0155","series-title":"Rare Diseases in Latin America: Challenges and Opportunities for the Equitable Attention and Proposal of Patients Organizations","author":"Chavez","year":"2017"},{"issue":"4","key":"10.1016\/j.ymgmr.2024.101060_bb0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5582\/irdr.2018.01085","article-title":"A compilation of national plans, policies and government actions for rare diseases in 23 countries","volume":"7","author":"Khosla","year":"2018","journal-title":"Intractable Rare Dis. Res."},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101060_bb0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1055\/s-0043-1761434","article-title":"Clinical management and diagnosis of CLN2 disease: consensus of the Brazilian experts group","volume":"81","author":"Sampaio","year":"2023","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101060_bb0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymgme.2007.08.124","article-title":"CLN2\/TPP1 deficiency: the novel mutation IVS7-10A>G causes intron retention and is associated with a mild disease phenotype","volume":"93","author":"Bessa","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"8","key":"10.1016\/j.ymgmr.2024.101060_bb0175","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.ymgmr.2024.101060_bb0180","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1101\/gr.9.8.677","article-title":"SK. dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation - PubMed","volume":"9","author":"Sherry","year":"1999","journal-title":"Genome Res. [Internet]"},{"key":"10.1016\/j.ymgmr.2024.101060_bb0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.genom.7.080505.115630","article-title":"Predicting the effects of amino acid substitutions on protein function","volume":"7","author":"Ng","year":"2006","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"7","key":"10.1016\/j.ymgmr.2024.101060_bb0190","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101060_bb0195","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/EBC20170114","article-title":"Emerging therapies for mitochondrial diseases","volume":"62","author":"Hirano","year":"2018","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ymgmr.2024.101060_bb0200","first-page":"721","article-title":"Lack of information on the effects of COVID-19 on rare pathologies has further hampered access to healthcare services","author":"Severin","year":"2022","journal-title":"Front. Public Health"}],"updated-by":[{"DOI":"10.1016\/j.ymgmr.2024.101081","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000}}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T02:17:16Z","timestamp":1734574636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426924000132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":40,"alternative-id":["S2214426924000132"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101060","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ymgmr.2024.101081","asserted-by":"object"}]},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and Genetic Aspects, and Treatment Outcome with Cerliponase Alfa","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101060"}}